FR2370755A1 - Spirolactones steroidiques et medicaments qui en contiennent - Google Patents

Spirolactones steroidiques et medicaments qui en contiennent

Info

Publication number
FR2370755A1
FR2370755A1 FR7734434A FR7734434A FR2370755A1 FR 2370755 A1 FR2370755 A1 FR 2370755A1 FR 7734434 A FR7734434 A FR 7734434A FR 7734434 A FR7734434 A FR 7734434A FR 2370755 A1 FR2370755 A1 FR 2370755A1
Authority
FR
France
Prior art keywords
spirolactons
steroidic
products containing
medicinal products
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7734434A
Other languages
English (en)
Other versions
FR2370755B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5993550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2370755(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering AG filed Critical Schering AG
Publication of FR2370755A1 publication Critical patent/FR2370755A1/fr
Application granted granted Critical
Publication of FR2370755B1 publication Critical patent/FR2370755B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Spirolactones stéroïdiques. Elles répondent à la formule :
FR7734434A 1976-11-16 1977-11-16 Spirolactones steroidiques et medicaments qui en contiennent Granted FR2370755A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2652761A DE2652761C2 (de) 1976-11-16 1976-11-16 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
FR2370755A1 true FR2370755A1 (fr) 1978-06-09
FR2370755B1 FR2370755B1 (fr) 1980-06-06

Family

ID=5993550

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7734434A Granted FR2370755A1 (fr) 1976-11-16 1977-11-16 Spirolactones steroidiques et medicaments qui en contiennent

Country Status (23)

Country Link
US (1) US4129564A (fr)
JP (2) JPS5363373A (fr)
AT (1) AT356827B (fr)
AU (1) AU512611B2 (fr)
BE (1) BE860877A (fr)
CA (1) CA1092094A (fr)
CH (2) CH631463A5 (fr)
CS (1) CS194823B2 (fr)
DD (1) DD132968B3 (fr)
DE (1) DE2652761C2 (fr)
DK (1) DK141967C (fr)
ES (1) ES464193A1 (fr)
FR (1) FR2370755A1 (fr)
GB (1) GB1550568A (fr)
GR (1) GR65227B (fr)
HU (1) HU174983B (fr)
IE (1) IE46076B1 (fr)
IL (1) IL53353A (fr)
IT (1) IT1092262B (fr)
LU (1) LU78514A1 (fr)
NL (1) NL7711946A (fr)
SE (1) SE436425B (fr)
SU (2) SU695560A3 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0061418A1 (fr) * 1981-03-23 1982-09-29 Schering Aktiengesellschaft 7-Alpha-alcoxycarbonyl-15bêta 16bêta-méthylène 4-androstènes, procédé de préparation et utilisation comme médicaments
EP0075189A1 (fr) * 1981-09-21 1983-03-30 Schering Aktiengesellschaft 3-Bêta,7-bêta,15-alpha-trihydroxy-5-androstène-17-one, son 3,15-dipivalate et sa préparation
EP0091881A1 (fr) * 1982-04-13 1983-10-19 Schering Aktiengesellschaft 1-Alpha,2-alpha;6-bêta,7-bêta;15-bêta,16-bêta-triméthylène-3-oxo-17-alpha-pregn-4-ène-21,17-carbolactone, sa préparation et son utilisation en thérapeutique
EP0099853A2 (fr) * 1982-07-22 1984-02-01 Schering Aktiengesellschaft 7-Alpha-acylthio-15,16-méthylène-3-oxo-17-alpha-prégna-1,4-diène-21,17-carbolactones, leur procédé de préparation et utilisation dans des médicaments
EP0106793A1 (fr) * 1982-09-17 1984-04-25 Schering Aktiengesellschaft 7-Alpha-alcoyle-17-alpha-pregn-4-ene-21,17-carbolactones et les sels de l'acide -21-carboxylique, procédés pour les préparer et compositions pharmaceutiques les contenant
EP0122232A1 (fr) * 1983-04-13 1984-10-17 Ciba-Geigy Ag 20-Spiroxanes et analogues à cycle E ouvert, procédé de préparation et préparations pharmaceutiques
EP0150157A2 (fr) * 1984-01-20 1985-07-31 Schering Aktiengesellschaft 6,6-Ethylène-15,16-méthylène-3-oxo-17-alpha-pregn-4-ène-21-17 carbolactone, procédé pour les préparer et compositions pharmaceutiques les contenant
EP0165902A2 (fr) * 1984-06-21 1985-12-27 Ciba-Geigy Ag Stéroides époxydes
WO1987003599A1 (fr) * 1985-12-13 1987-06-18 Schering Aktiengesellschaft Berlin Und Bergkamen PROCEDE DE PRODUCTION DE 7alpha-ACETYLTHIOSTEROIDES

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2922500A1 (de) * 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
DE3022337A1 (de) * 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
DE3051166C2 (en) * 1980-06-11 1990-10-18 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De Compsns. for contraception or treatment of gynaecological disorders
DE3240510A1 (de) * 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 7(alpha)-acylthio-1(alpha),2(alpha)-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, deren herstellung und diese enthaltende arzneimittel
JPS59139400A (ja) * 1983-01-31 1984-08-10 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体
DE3306554A1 (de) * 1983-02-22 1984-08-23 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 3-((delta)(pfeil hoch)4(pfeil hoch)-3-ketosteroid-17(alpha)-yl)-propionsaeurelactonen
EP0134529B1 (fr) * 1983-08-17 1990-03-21 Schering Aktiengesellschaft 3-Oxo-17-alpha-pregn-4-ene-21-17-carbolactone substituées en 7-alpha, procédé pour les préparer et compositions pharmaceutiques les contenant
DE3347510A1 (de) * 1983-12-27 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 3-oxo-17(alpha)-pregna-4,6-dien-21,17-carbolactonen
JPS6248694A (ja) * 1985-08-28 1987-03-03 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体
JPS62132932U (fr) * 1986-02-14 1987-08-21
US4837211A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Spironolactone composition
JPS6453026U (fr) * 1987-09-29 1989-03-31
DE3916112A1 (de) * 1989-05-16 1990-11-22 Schering Ag Dihydrospirorenon als antiandrogen
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
IL122246A (en) * 1995-06-07 2004-06-01 Searle & Co Combination of spironolactone and angiotensin II antagonist for the treatment of heart failure
DE19633685C1 (de) * 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
DE19651000A1 (de) * 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
BR9915134A (pt) * 1998-11-06 2001-08-07 Searle & Co Co-terapia e terapia combinada para o tratamento de distúrbio cardiovascular em um indivìduo, e, composição
UA81387C2 (en) * 1999-08-31 2008-01-10 Schering Ag Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
EP1380301B1 (fr) 1999-08-31 2009-01-14 Bayer Schering Pharma Aktiengesellschaft Combinaison pharmaceutique d'éthinylestradiol et de drospirénone comme contraceptif
EP2305267A3 (fr) 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Combinaison pharmaceutique de l'éthinylestradiol et de la drospirénone pour utilisation comme contraceptif
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
CZ20022411A3 (cs) * 2000-01-18 2003-02-12 Schering Aktiengesellschaft Drospirenon pro hormonální substituční léčbu
CA2416152A1 (fr) * 2000-07-27 2002-02-07 Pharmacia Corporation Therapie anti-aldosterones destinee a prevenir ou traiter les troubles lies a une inflammation
US6716829B2 (en) 2000-07-27 2004-04-06 Pharmacia Corporation Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
EP1216713A1 (fr) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions de complexes de estrogen-cyclodextrine
EP1216712A1 (fr) 2000-12-20 2002-06-26 Schering Aktiengesellschaft Complexes d'inclusion de drospirenone et de cyclodextrines
EP1406634A1 (fr) * 2001-07-13 2004-04-14 Schering Aktiengesellschaft Combinaison de drospirenone et d'un sulfamate d'oestrogene destinee a une hormonotherapie substitutive
WO2003080068A1 (fr) * 2002-03-18 2003-10-02 Pharmacia Corporation Combinaison d'antagoniste de recepteur d'aldosterone et d'acide nicotinique ou d'un derive d'acide nicotinique
US20030219401A1 (en) * 2002-03-18 2003-11-27 Keller Bradley T. Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
ITMI20040367A1 (it) * 2004-03-01 2004-06-01 Ind Chimica Srl Processo per la preparazione di drospirenone
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
HUP0402466A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main, intermediates of the process
HUP0402465A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main intermediates of the process
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
MX2008016571A (es) 2007-05-01 2009-03-09 Sicor Inc Proceso para preparar drospirenona y su intermediarios.
FR2917975B1 (fr) 2007-06-26 2009-10-16 Ceva Sante Animale Sa Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains
US20090035373A1 (en) * 2007-07-31 2009-02-05 Katrin Mittmann Pharmaceutical composition for contraception and blood pressure regulation, kit for contraception containing same and method of production of same
US20090035374A1 (en) * 2007-07-31 2009-02-05 Katrin Mittmann Method of making a single-stage pharmaceutical preparation for oral therapy to regulate blood pressure and kit containing same
HUP0700826A3 (en) 2007-12-20 2010-03-29 Richter Gedeon Nyrt Coated tablet containing drospirenone and process for producing the same
WO2009111574A2 (fr) * 2008-03-05 2009-09-11 Evestra, Inc. Carbolactones de bisméthylène-17α et utilisations associées
US8222237B2 (en) * 2008-11-25 2012-07-17 Evestra, Inc. Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones
EP2398467A1 (fr) 2009-02-18 2011-12-28 Bayer Pharma Aktiengesellschaft Particules comprenant de la drospirénone encapsulée dans un polymère
EP2398461A1 (fr) 2009-02-18 2011-12-28 Bayer Pharma Aktiengesellschaft Fo0rmulation comprenant de la drospirenone pour administration souscutanee ou intramusculaire
US8334375B2 (en) * 2009-04-10 2012-12-18 Evestra, Inc. Methods for the preparation of drospirenone
ES2432063T3 (es) 2009-06-16 2013-11-29 Crystal Pharma, S.A.U. Procedimiento para la obtención de 17-espirolactonas en esteroides
ES2566934T3 (es) 2010-05-10 2016-04-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Métodos y composiciones para el tratamiento de la acumulación de líquido en y/o bajo la retina
JP6180930B2 (ja) 2010-06-16 2017-08-16 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 創傷治癒過程における再上皮化を刺激するための方法及び組成物
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
CN102887934B (zh) * 2012-09-20 2015-05-27 杭州福斯特药业有限公司 一种屈螺酮的制备方法
WO2016063269A1 (fr) 2014-10-20 2016-04-28 Prendergast Patrick T Utilisation d'antagonistes au récepteur stéroïdien nucléaire, seuls ou en association, comme agents antiviraux directs pour inhiber des alphavirus, togavirus, filovirus, arénavirus, bunyavirus, flavivirus et rhabdovirus
BR112017028048A2 (pt) 2015-06-23 2018-09-04 Laboratorios Leon Farma Sa drospirenona como o único ingrediente contraceptivo para uso
EP3108889A1 (fr) 2015-06-23 2016-12-28 Philippe Perrin Contraceptif à base de drospirenone pour un patient féminin ayant un excès de poids
WO2017055248A1 (fr) 2015-09-28 2017-04-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes et compositions pharmaceutiques pour le traitement d'une insuffisance cardiaque
WO2017064121A1 (fr) 2015-10-13 2017-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes et compositions pharmaceutiques pour le traitement de la néovascularisation choroïdienne
WO2018019843A1 (fr) 2016-07-26 2018-02-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagonistes du récepteur des minéralocorticoïdes pour le traitement de l'arthrose
EP4134082A1 (fr) 2021-08-12 2023-02-15 Chemo Research, S.L. Procédé de traitement de l'endométriose et de fourniture de contraception efficace
EP4395785A1 (fr) 2021-08-31 2024-07-10 Inserm (Institut National de la Santé et de la Recherche Scientifique) Méthodes de traitement de la rosacée oculaire
WO2023152658A1 (fr) 2022-02-10 2023-08-17 Lupin Limited Composition de comprimé de drospirénone à libération lente
AR128632A1 (es) 2022-03-01 2024-05-29 Chemo Res S L Anticonceptivo oral masticable de drospirenona

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE730163A (fr) * 1968-03-22 1969-09-22

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3257390A (en) * 1963-06-12 1966-06-21 Merck & Co Inc Ring a unsaturated 21-hydroxy-3-oxo-17alpha-pregnane-17-carboxylic acid lactone diuretic agents
DE2237143A1 (de) * 1972-07-28 1974-02-14 Hoechst Ag Verfahren zur herstellung von beta(3-keto-7alpha-acetylthio-17beta-hydroxy4-androsten-17alpha-yl)-propionsaeuregamma-lacton und dessen 1-dehydro-derivat
CH601352A5 (fr) * 1973-09-26 1978-07-14 Hoffmann La Roche

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE730163A (fr) * 1968-03-22 1969-09-22

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0061418A1 (fr) * 1981-03-23 1982-09-29 Schering Aktiengesellschaft 7-Alpha-alcoxycarbonyl-15bêta 16bêta-méthylène 4-androstènes, procédé de préparation et utilisation comme médicaments
EP0075189A1 (fr) * 1981-09-21 1983-03-30 Schering Aktiengesellschaft 3-Bêta,7-bêta,15-alpha-trihydroxy-5-androstène-17-one, son 3,15-dipivalate et sa préparation
EP0091881A1 (fr) * 1982-04-13 1983-10-19 Schering Aktiengesellschaft 1-Alpha,2-alpha;6-bêta,7-bêta;15-bêta,16-bêta-triméthylène-3-oxo-17-alpha-pregn-4-ène-21,17-carbolactone, sa préparation et son utilisation en thérapeutique
EP0099853A2 (fr) * 1982-07-22 1984-02-01 Schering Aktiengesellschaft 7-Alpha-acylthio-15,16-méthylène-3-oxo-17-alpha-prégna-1,4-diène-21,17-carbolactones, leur procédé de préparation et utilisation dans des médicaments
EP0099853A3 (en) * 1982-07-22 1984-04-18 Schering Aktiengesellschaft Berlin Und Bergkamen 7-alpha-acylthio-15,16-methylene-3-oxo-17-alpha-pregna-1,4-diene-21,17-carbolactones, their preparation and use as medicinal agents
EP0106793A1 (fr) * 1982-09-17 1984-04-25 Schering Aktiengesellschaft 7-Alpha-alcoyle-17-alpha-pregn-4-ene-21,17-carbolactones et les sels de l'acide -21-carboxylique, procédés pour les préparer et compositions pharmaceutiques les contenant
EP0122232A1 (fr) * 1983-04-13 1984-10-17 Ciba-Geigy Ag 20-Spiroxanes et analogues à cycle E ouvert, procédé de préparation et préparations pharmaceutiques
EP0150157A2 (fr) * 1984-01-20 1985-07-31 Schering Aktiengesellschaft 6,6-Ethylène-15,16-méthylène-3-oxo-17-alpha-pregn-4-ène-21-17 carbolactone, procédé pour les préparer et compositions pharmaceutiques les contenant
EP0150157A3 (en) * 1984-01-20 1985-08-28 Schering Aktiengesellschaft Berlin Und Bergkamen 6,6-ethylene-15,16-methylene-3-oxo-17-alpha-pregn-4-ene 21-17 carbolactone, process for their preparation and pharmaceutical compositions containing them
EP0165902A2 (fr) * 1984-06-21 1985-12-27 Ciba-Geigy Ag Stéroides époxydes
EP0165902A3 (en) * 1984-06-21 1986-10-22 Ciba-Geigy Ag Epoxy steroids
WO1987003599A1 (fr) * 1985-12-13 1987-06-18 Schering Aktiengesellschaft Berlin Und Bergkamen PROCEDE DE PRODUCTION DE 7alpha-ACETYLTHIOSTEROIDES
EP0226101A1 (fr) * 1985-12-13 1987-06-24 Schering Aktiengesellschaft Procédé de préparation de 7-alpha-acétyl-thiostéroides

Also Published As

Publication number Publication date
NL7711946A (nl) 1978-05-18
DD132968B3 (de) 1991-03-28
JPS61218595A (ja) 1986-09-29
DE2652761A1 (de) 1978-05-18
CH632774A5 (de) 1982-10-29
CH631463A5 (de) 1982-08-13
DK141967B (da) 1980-07-28
IT1092262B (it) 1985-07-06
LU78514A1 (fr) 1978-03-20
SE7712891L (sv) 1978-05-17
AT356827B (de) 1980-05-27
DE2652761C2 (de) 1985-11-21
IL53353A0 (en) 1978-01-31
CA1092094A (fr) 1980-12-23
DD132968A5 (de) 1978-11-22
CS194823B2 (en) 1979-12-31
US4129564A (en) 1978-12-12
DK508077A (da) 1978-05-17
GR65227B (en) 1980-07-30
SU743582A3 (ru) 1980-06-25
ATA815577A (de) 1979-10-15
AU3050977A (en) 1979-05-17
IL53353A (en) 1982-04-30
JPH0242840B2 (fr) 1990-09-26
SE436425B (sv) 1984-12-10
AU512611B2 (en) 1980-10-16
JPS6156240B2 (fr) 1986-12-01
IE46076B1 (en) 1983-02-09
IE46076L (en) 1978-05-16
DK141967C (da) 1980-12-08
SU695560A3 (ru) 1979-10-30
BE860877A (fr) 1978-05-16
HU174983B (hu) 1980-04-28
GB1550568A (en) 1979-08-15
JPS5363373A (en) 1978-06-06
FR2370755B1 (fr) 1980-06-06
ES464193A1 (es) 1978-09-01

Similar Documents

Publication Publication Date Title
FR2370755A1 (fr) Spirolactones steroidiques et medicaments qui en contiennent
BE826923A (fr) (polyacoxy-phenyl)-4-pyrrolidinones-2 medicaments qui en contiennent
BE846335R (fr) (polyalcoxy-phenyl)-4-pyrrolidinones-2 et medicaments qui en contiennent
NL7505574A (nl) Medicinale katamentale tampon.
BE851590A (fr) Compositions pharmaceutiques renfermant des pyrethrinoides
SE7709359L (sv) Farmaceutisk doseringsform
FR2295739A1 (fr) Oxo-20 homopregnanes et medicaments qui en contiennent
FR2433512A1 (fr) Derives de l'indane et medicaments qui en contiennent
FR2281123A1 (fr) Oxo-20 pregnanes et medicaments qui en contiennent
FR2326927A1 (fr) Steroides insatures en 15 et medicaments qui en contiennent
BE849788A (fr) Ethers d'imidazolyl-oximes et medicaments qui en contiennent
FR2342990A1 (fr) Androstenones et medicaments qui en contiennent
BE862433A (fr) Compositions medicamenteuses contenant des sterolines et leurs applications therapeutiques
FR2287909A1 (fr) Hydroxy-1a steroides et medicaments qui en contiennent
FR2366312A1 (fr) Corticosteroides et medicaments qui en contiennent
BE877511A (fr) Medicaments du groupe des spirocetalines
FR2391224A1 (fr) Hydroxy-androstenones et medicaments qui en contiennent
FR2307526A1 (fr) Oxo-11 prostaglandines et medicaments qui en contiennent
FR2428649A1 (fr) Diesters en 17,21 de l'hydrocortisone et medicaments qui en contiennent
FR2373561A1 (fr) Corticosteroides et medicaments qui en contiennent
FR2366313A1 (fr) Derives de la chloro-9 prednisolone et medicaments qui en contiennent
FR2384794A1 (fr) Methylene-1a,2a steroides et medicaments qui en contiennent
FR2347925A1 (fr) Medicaments, cosmetiques et pesticides renfermant des fluoroacyl-resorcines
FR2422689A1 (fr) Steroides de la serie du pregnane a groupe hydroxy etherifie en position 17 et medicaments qui en contiennent
FR2381036A1 (fr) Benzotriazines-1,2,4 et medicaments qui en contiennent